CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 2,284 shares (grant or award)
- 4 Open-market buy Director bought 13,000 shares at $3.91 ($50,778)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,087 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,184 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,154 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 8,549 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 91 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 151 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 157 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 981 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer and GC acquired 3,664 shares (grant or award)
- 4 Grant or award President and CEO acquired 2,766 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 384 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 480 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 478 shares (to pay taxes)
Page 6 of 17 · 330 filings